B. Simitcioglu Et Al. , "Effect of different molecular weight and terminal group PLGA on docetaxel nanoparticles: characterization and cytotoxic activity of castration-resistant prostate cancer cells," Pharmaceutical Development and Technology , vol.27, no.7, pp.794-804, 2022
Simitcioglu, B. Et Al. 2022. Effect of different molecular weight and terminal group PLGA on docetaxel nanoparticles: characterization and cytotoxic activity of castration-resistant prostate cancer cells. Pharmaceutical Development and Technology , vol.27, no.7 , 794-804.
Simitcioglu, B., Karagoz, I. D., Ilbasmis-Tamer, S., & Tamer, U., (2022). Effect of different molecular weight and terminal group PLGA on docetaxel nanoparticles: characterization and cytotoxic activity of castration-resistant prostate cancer cells. Pharmaceutical Development and Technology , vol.27, no.7, 794-804.
Simitcioglu, Basak Et Al. "Effect of different molecular weight and terminal group PLGA on docetaxel nanoparticles: characterization and cytotoxic activity of castration-resistant prostate cancer cells," Pharmaceutical Development and Technology , vol.27, no.7, 794-804, 2022
Simitcioglu, Basak Et Al. "Effect of different molecular weight and terminal group PLGA on docetaxel nanoparticles: characterization and cytotoxic activity of castration-resistant prostate cancer cells." Pharmaceutical Development and Technology , vol.27, no.7, pp.794-804, 2022
Simitcioglu, B. Et Al. (2022) . "Effect of different molecular weight and terminal group PLGA on docetaxel nanoparticles: characterization and cytotoxic activity of castration-resistant prostate cancer cells." Pharmaceutical Development and Technology , vol.27, no.7, pp.794-804.
@article{article, author={Basak Simitcioglu Et Al. }, title={Effect of different molecular weight and terminal group PLGA on docetaxel nanoparticles: characterization and cytotoxic activity of castration-resistant prostate cancer cells}, journal={Pharmaceutical Development and Technology}, year=2022, pages={794-804} }